Plasma chemerin levels in patients with multiple sclerosis

Neuroendocrinology Letters

Volumn 35, Issue 3, 2014, Pages 218-223

  Tomalka Kochanowska, Joanna ^a   Baranowska, Boguslawa ^a   Wolinska Witort, Ewa ^b   Uchman, Dorota ^a   Litwiniuk, Anna ^b   Martynska, Lidia ^b   Kalisz, Małgorzata ^b   Bik, Wojciech ^b   Kochanowski, Jan ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

Chemerin; Multiple sclerosis

Indexed keywords

C REACTIVE PROTEIN; CHEMERIN; CHOLESTEROL; GADOLINIUM; GLUCOSE; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN G; INSULIN; INTERLEUKIN 10; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; OLIGOCLONAL BAND; TRIACYLGLYCEROL; CHEMERIN, HUMAN; CHEMOKINE;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; LEAN BODY WEIGHT; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PROTEIN BLOOD LEVEL; ADOLESCENT; BLOOD; BODY WEIGHT; CASE CONTROL STUDY; COMPLICATION; MIDDLE AGED; OVERWEIGHT; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHEMOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OBESITY; OVERWEIGHT; THINNESS; YOUNG ADULT;

EID: 84905496696     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Barnea G, Strapps W, Herrada G, Berman Y, Ong J, Kloss B, et al. (2008). The genetic design of signaling cascades to record receptor activation. Proc Natl Acad Sci US A. 105: 64-69.
2. Bauer S, Bala M, Kopp A, Eisinger K, Schmid A, Schneider S, et al. (2012). Adipocyte chemerin release is induced by insulin without being translated to higher levels in vivo. Eur J Clin Invest. 42: 1213-1220.
3. Bauer S, Wanninger J, Schmidhofer S, Weigert J, Neumeier M, Dorn C, et al. (2011). Sterol regulatory element-binding protein 2 (SREBP2) activation after excess triglyceride storage induces chemerin in hypertrophic adipocytes. Endocrinology. 152: 26-35.
4. Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G, et al. (2007). Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology. 148: 4687-94. (Pubitemid 47481514)
5. Bozaoglu K, Curran JE, Stocker CJ, Zaibi MS, Segal D, Konstantopoulos N, et al. (2010). Chemerin, a novel adipokine in the regulation of angiogenesis. J Clin Endocrinol Metab. 95: 2476-2485.
6. Bozaoglu K, Segal D, Shields KA, Cummings N, Curran JE, Comuzzie AG, et al. (2009). Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. J Clin Endocrinol Metab. 94: 3085-3088.
7. Bremer AA, Jialal I (2013). Adipose tissue dysfunction in nascent metabolic syndrome. J Obes. 2013:393192. doi: 10.1155/2013/393192.
8. Chu SH, Lee MK, Ahn KY, Im JA, Park MS, Lee DC, et al. (2012). Chemerin and adiponectin contribute reciprocally to metabolic syndrome. PLoS One.7: e34710.
9. Ernst MC, Sinal CJ (2010). Chemerin: at the crossroads of inflammation and obesity. Trends Endocrinol Metab. 21: 660-667.
10. Graham KL, Zabel BA, Loghavi S, Zuniga LA, Ho PP, Sobel RA, et al. (2009). Chemokine-like receptor-1 expression by central nervous system-infiltrating leukocytes and involvement in a model of autoimmune demyelinating disease. J Immunol. 183: 6717-6723.
11. Gu P, Jiang W, Lu B, Shi Z (2013). Chemerin is associated with inflammatory markers and metabolic syndrome phenotypes in hypertension patients. Clin Exp Hypertens. [Epub ahead of print]
12. Hedström AK, Lima Bomfim I, Barcellos L, Gianfrancesco M, Schaefer C, Kockum I, et al. (2014). Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis. Neurology. 82: 865-872.
13. Hedström AK, Olsson T, Alfredsson L (2012). High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult Scler. 18: 1334-1336.
14. de Heredia FP, Gómez-Martínez S, Marcos A (2012). Obesity, inflammation and the immune system. Proc Nutr Soc. 7: 332-338.
15. Hotamisligil GS (2006). Inflammation and metabolic disorders. Nature. 444: 860-867.
16. Jialal I, Devaraj S, Kaur H, Adams-Huet B, Bremer AA (2013). Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. J Clin Endocrinol Metab. 98: E514-7.
17. Kaur J, Adya R, Tan BK, Chen J, Randeva HS (2010). Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis. Biochem Biophys Res Commun. 391: 1762-1768.
18. Kralisch S, Weise S, Sommer G, Lipfert J, Lossner U, Bluher M, et al. (2009). Interleukin-1 beta induces the novel adipokine chemerin in adipocytes in vitro. Regul Pept. 154: 102-106.
19. Langer-Gould A, Brara SM, Beaber BE, Koebnick C (2013). Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome. Neurology. 80: 548-552.
20. Lumeng CN, Bodzin JL, Saltiel AR (2007). Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 117: 175-184. (Pubitemid 46048464)
21. Matarese G, Procaccini C, De Rosa V (2008). The intricate interface between immune and metabolic regulation: a role for leptin in the pathogenesis of multiple sclerosis? J Leukoc Biol. 84: 893-899.
22. Mattu HS, Randeva HS (2013). Role of adipokines in cardiovascular disease. J Endocrinol. 216: T17-36.
23. Mikita J, Dubourdieu-Cassagno N, Deloire MS, Vekris A, Biran M, Raffard G, et al. (2011). Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult Scler. 17: 2-15.
24. Monnier J, Lewén S, O'Hara E, Huang K, Tu H, Butcher EC, et al. (2012). Expression, regulation, and function of atypical chemerin receptor CCRL2 on endothelial cells. J Immunol. 189: 956-967.
25. Monteiro R, Azevedo I (2010). Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm. 2010; doi: 10.1155/2010/289645.
26. Munger KL, Chitnis T, Ascherio A (2009). Body size and risk of MS in two cohorts of US women. Neurology, 73: 1543-1550.
27. Onkamo P, Väänänen S, Karvonen M, Tuomilehto J (1999). Worldwide increase in incidence of Type I diabetes - the analysis of the data on published incidence trends. Diabetologia. 42: 1395-1403. (Pubitemid 30012309)
28. Parolini S, Santoro A, Marcenaro E, Luini W, Massardi L, Facchetti F, et al. (2007). The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood. 109: 3625-3632. (Pubitemid 46641708)
29. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. (2011). Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 69: 292-302.
30. Roman AA, Parlee SD, Sinal CJ (2012) Chemerin: a potential endocrine link between obesity and type 2 diabetes. Endocrine. 42: 243-251.
31. Rostami A, Ciric B (2013). Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination. J Neurol Sci. 333: 76-87.
32. Sell H, Laurencikiene J, Taube A, Eckardt K, Cramer A, Horrighs A, et alJ (2009). Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes. 58: 2731-2740.
33. Warren SA, Svenson LW, Warren KG (2008). Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, Canada. Mult Scler. 14: 872-879.
34. Weigert J, Neumeier M, Wanninger J, Filarsky M, Bauer S, Wiest R, et al. (2010). Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol (Oxf) 72: 342-348.
35. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr (2003). Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 112: 1796-1808. (Pubitemid 38063703)
36. Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, Migeotte I, et al. (2003). Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med. 198: 977-985. (Pubitemid 37248614)
37. Yamawaki H, Kameshima S, Usui T, Okada M, Hara Y (2012). A novel adipocytokine, chemerin exerts anti-inflammatory roles in human vascular endothelial cells. Biochem Biophys Res Commun. 423: 152-157.
38. Zabel BA, Allen SJ, Kulig P, Allen JA, Cichy J, Handel TM, et al. (2005). Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. J Biol Chem. 280: 34661-34666. (Pubitemid 41504597)
39. Zabel BA, Nakae S, Zúñiga L, Kim JY, Ohyama T, Alt C, et al. (2008). Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis. J Exp Med. 205: 2207-2220.
40. Zabel BA, Zuniga L, Ohyama T, Allen SJ, Cichy J, Handel TM, et al. (2006) Chemoattractants, extracellular proteases, and the integrated host defense response. Exp Hematol. 34: 1021-1032. (Pubitemid 44080389)